sponsored
PatientsVille.com Logo

PatientsVille

Alvesco Medical Research Studies

Up-to-date List of Alvesco Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Alvesco Medical Research Studies

Rank Status Study
1 Recruiting A Study Evaluating the Effect of Inhaled and Nasal Corticosteroids on Short Term Growth in Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Conditions: Asthma;   Allergic Rhinitis
Interventions: Drug: Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo;   Drug: Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase;   Drug: QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo;   Drug: QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris;   Drug: Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase;   Drug: Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
Outcome Measures: The effect of Omnaris Nasal Spray & Alvesco Inhalation Aerosol vs Beconase AQ Nasal Spray & QVAR Inhalation Aerosol on short-term lower leg growth velocity as measured by knemometry in pediatric subjects w/ mild asthma & allergic rhinitis.;   The Effects of Omnaris, Alvesco, Beconase AQ and QVAR vs Placebo Nasal Spray & Placebo Inhalation Aerosol on short-term lower leg growth velocity as measured by knemometry in pediatric subjects w/ mild asthma & allergic rhinitis.
2 Not yet recruiting Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Ciclesonide;   Drug: Ciclesonide Placebo
Outcome Measures: Change from Baseline in Patient-Reported AM and PM Reflective Total Nasal Symptom Scores (TNSS) Over the 2-Week Treatment Period;   Change from Baseline in Patient-Reported AM and PM Instantaneous Total Nasal Symptom Scores (TNSS) Over the 2-Week Treatment Period;   Change from Baseline in Patient-Reported AM and PM Reflective and Instantaneous Total Ocular Symptom Scores (TOSS) Over the 2-Week Treatment Period;   Change from Baseline in Patient-Reported Individual AM and PM Reflective TNSS Symptoms Over the 2-Week Treatment Period;   Change from Baseline in Patient-Reported Individual AM and PM Reflective TOSS Symptoms Over the 2-Week Treatment Period;   Change from Baseline in Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) Total and Individual Items Over the 2-Week Treatment Period
3 Recruiting Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With Asthma
Condition: Asthma
Interventions: Drug: cyklezonid;   Drug: montelukast sodium;   Drug: placebo;   Drug: formoterol 12 mcg twice daily
Outcome Measures: Measurement of IL-4, 5, 6, 8, 16, MIG, TNF- alpha, MCP-1 in EBC. Measurement of ECP, eosinophil blood count, cotinine and total IgE in blood.;   Measurement of FENO, bronchial hyperreactivity, exercise treadmill challenge, lung function and clinical evaluation

These studies may lead to new treatments and are adding insight into Alvesco etiology and treatment.

A major focus of Alvesco research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Alvesco